USA Financial Formulas’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $56.3K | Buy |
+767
| New | +$56.3K | 0.01% | 201 |
|
2025
Q1 | – | Sell |
-1,065
| Closed | -$53.7K | – | 297 |
|
2024
Q4 | $53.7K | Buy |
+1,065
| New | +$53.7K | 0.01% | 235 |
|
2021
Q1 | – | Sell |
-2,401
| Closed | -$63K | – | 353 |
|
2020
Q4 | $63K | Buy |
+2,401
| New | +$63K | 0.05% | 169 |
|
2020
Q3 | – | Sell |
-17,606
| Closed | -$296K | – | 330 |
|
2020
Q2 | $296K | Buy |
+17,606
| New | +$296K | 0.22% | 67 |
|
2017
Q4 | – | Sell |
-34,091
| Closed | -$658K | – | 275 |
|
2017
Q3 | $658K | Buy |
+34,091
| New | +$658K | 0.16% | 119 |
|
2017
Q1 | – | Sell |
-38,601
| Closed | -$280K | – | 257 |
|
2016
Q4 | $280K | Buy |
+38,601
| New | +$280K | 0.07% | 198 |
|